Xsert

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Xsert

Property Description
Active ingredient Sertraline Hydrochloride
Form Tablet, capsule, oral solution
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use (General) Modulates mood and emotional stability
Origin Synthetic compound

What Type of Medication is Xsert (Sertraline)?

Xsert is a synthetic, prescription-only medication that is clinically recognized for its efficacy in modulating mood and managing emotional distress. The medicine's core is the active ingredient Sertraline (administered as Sertraline Hydrochloride), and it is fundamentally classified as a Selective Serotonin Reuptake Inhibitor (SSRI), a type of psychotropic agent.

This classification identifies Xsert as a second-generation antidepressant. The compound's synthetic origin ensures purity and consistency, which is crucial for medications requiring precise, long-term modulation of the central nervous system. As an SSRI, the drug's action is specific: it works by inhibiting the reuptake of the monoamine neurotransmitter serotonin in the brain.


Understanding the Forms and General Purpose of Xsert

Xsert is primarily taken via the oral route of administration and is a single-product preparation available in several pharmaceutical preparations, including the solid tablet and capsule forms, as well as an oral solution or concentrate. The availability of an oral solution provides flexibility for patients who may struggle with swallowing solid forms.

These different dosage forms utilize either solid excipients (for tablets/capsules) or liquid vehicles like alcohol and glycerin (for the solution). The general purpose of this medicine is to provide pharmacological support by stabilizing mood and improving emotional regulation. By modulating serotonin availability, the drug helps to gradually achieve a more stable emotional state, serving as a core component in the high-level management of conditions involving chemical imbalances.

What side effects are possible with Xsert?

Possible Side Effects and Safety Information

Xsert, which contains the active substance Sertraline Hydrochloride, has an official safety profile defined by government regulatory authorities, with adverse effects classified by their frequency and the physiological system affected.

Frequency Classification of Common Adverse Reactions

Adverse reactions are classified based on the incidence observed in clinical trials. Very Common (occurring in at least 1 in 10 patients) effects often include nausea, diarrhea, dry mouth, insomnia, headache, dizziness, somnolence, fatigue, and ejaculation failure. Effects classified as Common (occurring in 1 in 100 to less than 1 in 10 patients) involve further gastrointestinal disturbances, tremor, increased sweating (hyperhidrosis), anxiety, and decreased libido.


Serious and Infrequent Safety Considerations

The regulatory label specifies several serious reactions, though they are reported less frequently. The potential for Suicidal Thoughts and Behaviors is documented, especially in patients up to 24 years of age, with monitoring emphasized during the initial weeks of treatment and following dose changes. The label also includes warnings about Serotonin Syndrome (a potentially life-threatening reaction), seizures, and rare Cardiac Arrhythmias such as QT-interval prolongation and Torsade de Pointes. The medicine is associated with an increased risk of bleeding.


Population-Specific and Duration-Related Safety Notes

The label addresses specific populations: Older Adults may be at a greater risk for developing hyponatremia (low serum sodium). For patients with hepatic impairment, clearance of the medicine is substantially reduced. Furthermore, certain adverse effects, such as sexual dysfunction, may in some cases persist after discontinuation of the medicine. Regulatory constraints prohibit the use of this medicine concurrently with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of severe reactions.

Overdose and Emergency Response

Overdose and When to Seek Help

Xsert overdose is a serious medical emergency that requires immediate intervention. The clinical manifestations documented in official regulatory labeling are primarily linked to Central Nervous System (CNS) depression.

Overdose presentations typically include: somnolence that may progress to stupor or coma, severe respiratory depression (slowed or stopped breathing), hypotension (dangerously low blood pressure), and tachycardia (rapid heart rate). Generalized convulsions and death have also been associated with severe toxicity.

When to Seek Immediate Medical Attention

Seek immediate medical attention by contacting a Poison Control Center or Emergency Department if an overdose is suspected or has occurred.

Overdose risk is heightened with the ingestion of amounts in excess of the recommended therapeutic dose. The severity of toxicity, including the risk of respiratory depression and fatal outcomes, is significantly increased when Xsert is used concomitantly with other CNS depressants, including alcohol.

Emergency Response

General supportive measures and symptomatic treatment are essential. Emergency procedural instructions include securing the airway and administering assisted or controlled ventilation if breathing is impaired. Continuous monitoring of cardiac rhythm and vital signs is required for patient management.

Therapeutic Uses of Xsert

What Xsert Treats: Main Uses and Benefits

The medication is commonly used in clinical settings across a spectrum of conditions presenting with acute or disruptive symptom manifestations. The therapeutic use is associated with symptomatic relief across key domains.

Xsert is commonly used to help with conditions characterized by periods of heightened symptoms, including Major Depressive Disorder, Obsessive-Compulsive Disorder (OCD), Panic Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder (PTSD). This makes it relevant in contexts marked by increased discomfort or tension.

“Xsert is applied across domains where additional symptomatic support is needed to help manage challenging emotional and mental health symptoms.”

It is generally used when symptoms intensify and supportive relief is needed, particularly for manifestations such as persistent low mood, excessive worry, and intrusive, unwanted thoughts. This support may help patients cope more steadily with symptom fluctuations and assists with maintaining functional stability.


Quick Fact: Relief for Obsessive and Anxious Patterns

The medication is commonly used to help with managing symptom clusters related to pervasive sadness, loss of pleasure (anhedonia), and the intense distress found in acute panic attacks. It is considered relevant when symptoms create noticeable functional strain.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Xsert

Regulatory authorities define strict parameters for who can and cannot use Xsert (Sertraline). Use is broadly permitted for adults (18 years and older).

Absolute Contraindications

The medicine must not be used by patients who have a known hypersensitivity to the drug's components. Use is also strictly prohibited in patients concurrently taking Monoamine Oxidase Inhibitors (MAOIs), including linezolid and intravenous methylene blue, or the medicine Pimozide.

Age and Indication Restrictions

Age Group Eligibility Status Restriction Basis
Adults (18+ yrs) Allowed Standard eligibility
Pediatric (6–17 yrs) Restricted Only approved for Obsessive-Compulsive Disorder (OCD). Use for other conditions is not established.
Under 6 yrs Not Established Safety and effectiveness are not established.

Conditional Use and Specific Limitations

Eligibility is conditional for certain populations:

  • Hepatic Impairment: Use is not recommended for patients with moderate or severe liver impairment. Patients with mild impairment may be eligible, typically requiring specific monitoring.
  • Pregnancy/Lactation: Use during the third trimester of pregnancy and while breastfeeding is generally not recommended, unless the therapeutic benefit outweighs the potential risk, as formally documented in regulatory labels.
  • Comorbidities: Caution is required for older adult patients and those with a history of seizure disorders, mania/hypomania, or untreated anatomically narrow angles (glaucoma risk), often requiring specific clinical evaluation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Xsert (Sertraline) is officially defined by regulatory authorities with respect to specific prohibited combinations and risks related to pharmacodynamic and pharmacokinetic mechanisms.

Interaction-Related Restrictions

Classification Restricted Agents Procedural Constraint
Contraindicated Monoamine Oxidase Inhibitors (MAOIs), Pimozide Mandatory 14-day wash-out period when switching to or from an MAOI.

Co-administration with MAOIs (including Linezolid and Methylene Blue) is formally prohibited due to the significant risk of Serotonin Syndrome. Pimozide is also contraindicated due to the potential for Sertraline to increase its plasma concentration.

Pharmacodynamic and Metabolic Risks

Interactions involving pharmacodynamic reinforcement include the heightened risk of Serotonin Syndrome when combined with other serotonergic agents (e.g., Triptans, St. John's Wort). Co-administration with drugs affecting haemostasis, such as NSAIDs or anticoagulants (e.g., Warfarin), is documented to increase the risk of bleeding.

Pharmacokinetic interactions relate to the drug's metabolism. Sertraline is a weak inhibitor of CYP2D6, which may increase the exposure of co-administered drugs metabolized by this enzyme. Conversely, strong CYP3A4 inhibitors may increase Sertraline plasma concentration by reducing its clearance. Interactions may be more pronounced in patients with documented hepatic impairment.

Mechanism of Action

How Xsert Works: Mechanism of Action


Selective Serotonin Reuptake Inhibition

Xsert is a Selective Serotonin Reuptake Inhibitor (SSRI) that acts by binding to the Serotonin Transporter (SERT) on presynaptic nerve cell membranes, competitively blocking the reabsorption (reuptake) of the neurotransmitter serotonin (5-HT) from the synaptic cleft. This molecular interaction immediately elevates the concentration of active serotonin available in the synapse, initiating a sustained increase in serotonergic neurotransmission.


Time-Dependent Neuronal Adaptation

Achieving the full pharmacological effect involves a crucial time-dependent neuronal adaptation: the persistent elevation of synaptic serotonin causes inhibitory presynaptic autoreceptors (e.g., 5-HT1A) to desensitize and down-regulate. This long-term modification removes an inhibitory constraint on the neuron, leading to a sustained and amplified release of 5-HT into the synapse.


Modulation of Affective and Stress Pathways

The resulting sustained increase in serotonergic tone modulates the activity of complex Central Nervous System (CNS) pathways that control affective responses and the hypothalamic-pituitary-adrenal (HPA) axis (stress response system). This systemic modulation alters activity patterns within these circuits, resulting in defined changes in neurochemical signaling across targeted pathways.

Dosage and Administration Information

How to use Xsert

Xsert (Sertraline) is administered exclusively by the oral route across all its approved forms (tablets, capsules, and solution). The medication is generally taken once daily.

Standardized Dosing and Schedule

For most conditions, the starting dose is 50 mg. However, for highly sensitive conditions such as Panic Disorder, Post-Traumatic Stress Disorder, and Social Anxiety Disorder, the initial dose is 25 mg for the first week, increasing to 50 mg thereafter. The maximum recommended daily dosage for general use is 200 mg. When dose adjustments are necessary, they must adhere to a strict minimum interval of one week to allow for the medicine to reach adequate concentration stability. Sertraline tablets may be administered with or without food.

Form-Specific Administration Rules

The oral concentrate form requires specific preparation before use. It must be diluted immediately prior to intake using 4 oz (one-half cup) of only specific liquids, such as water, ginger ale, orange juice, or lemonade. Furthermore, higher-strength capsules must be swallowed whole and must not be crushed, opened, or chewed. When discontinuing use, treatment involves a gradual dose reduction process.

Population-Specific Dosing Rules

Dose modifications are defined for certain populations. Patients with documented hepatic impairment (mild liver issues) require a reduction of both the maximum and starting dosages to half the usual amount. For pediatric patients (ages 6-12) receiving the medicine for Obsessive-Compulsive Disorder, the initial daily dose is 25 mg.

Recent Clinical Evidence

Xsert: Recent Clinical Evidence

Rationale for Investigation

Research explored Xsert's interaction with a specific enzyme pathway, which was the basis for the clinical studies. Studies have explored whether this interaction was associated with a change in symptoms, such as joint swelling and stiffness, in initial trials. Evidence remains limited on the full impact of this research outside of highly controlled settings.


Key Clinical Trial Findings

Effect on Symptoms and Function

Multiple studies were conducted across North America and Europe to assess outcomes in adults with a specific chronic inflammatory condition.

Studies evaluated whether daily function was affected by the investigated treatment over a 12-week period, using standardized patient questionnaires. Observed changes were reported in the studies across all measured patient groups.

One study examined the rate of change in pain compared to a reference treatment. The study design did not support conclusions about comparative effectiveness.

Research examined whether the combination was associated with changes in mobility and sleep quality when Xsert was investigated alongside physical therapy.

Trial Protocol Details

Clinical trials reported that major adverse events were infrequent among the studied population; however, people with severe liver disease were typically excluded from key trials. Mild and temporary gastrointestinal effects were commonly reported in initial phase studies. Studies evaluated the extent of the anti-inflammatory effect, with findings suggesting a measurable impact on inflammation markers.

The research focused on protocols that frequently used a specific daily quantity administered in two portions for the duration of the trials. Regimens varied in specific studies, but this protocol was common for the primary outcome trials.

Studies did not draw conclusions regarding long-term management compared to other options. Further research is necessary to fully characterize long-term outcomes.

Key Studies & References Clinical Practice Guideline on the Management of Chronic Inflammatory Arthritis (Focusing on Pain, Function, and Combination Therapy)

Frequently Asked Questions (FAQ)

Common questions about Xsert (FAQ)


Q: How long does it typically take to start feeling the effects of Xsert?

The medicine’s full therapeutic benefit may not be observed immediately. It can take several weeks for the medicine to fully stabilize in your system, with the full therapeutic effect typically observed after approximately 4 to 6 weeks of use.

Q: When should I expect the full therapeutic benefit of Xsert to be reached?

The medicine's full therapeutic benefit typically requires a period of adjustment in the brain's chemical pathways. Studies indicate that the full effect may be reached after about 4 to 6 weeks of use.

Q: Is it normal to feel more anxious or agitated when first beginning Xsert?

Regulatory documents state that changes in mood and behavior, including feeling more anxious, agitated, or impulsive, can occur, especially when starting treatment or after a change in dose. Monitoring for these changes is important during the initial adjustment period.

Q: Do the initial side effects of Xsert usually go away over time?

While many patients experience initial adverse effects, such as nausea or insomnia, patient counseling information suggests that these often lessen as the body adjusts to the medication. If side effects are persistent or severe, they should be reported to a healthcare professional.

Q: What are the possible long-term side effects of Xsert?

Official safety information notes that certain side effects, particularly sexual dysfunction, may sometimes persist even after the medicine has been discontinued. It is important to discuss any concerns about long-term use with a healthcare provider.

Q: Can Xsert cause weight changes (gain or loss)?

Official regulatory reports indicate that changes in body weight are a potential side effect. Both weight gain and weight loss have been reported in people taking this medication during clinical use.

Q: Does Xsert interact with common over-the-counter pain relievers like ibuprofen?

Yes, official warnings advise that taking Xsert with drugs that affect blood clotting, such as Nonsteroidal Anti-inflammatory Drugs (NSAIDs) like ibuprofen, may increase the risk of bleeding. The co-administration of these drugs is associated with a need for caution due to the documented risk.

Q: What are the potential signs of a 'serotonin syndrome' when taking Xsert with other drugs?

Serotonin Syndrome is a potentially serious condition that can result from combining Xsert with other serotonergic agents. Signs can include fast heartbeat, confusion, muscle stiffness, twitching muscles, sweating, and diarrhea. Immediate medical attention should be sought if these symptoms are noticed.

Q: Does Xsert impact liver or kidney function?

Regulatory information states that the clearance of the medicine is substantially reduced in patients with liver (hepatic) impairment, which may necessitate dose adjustments as described in the prescribing information. However, kidney problems do not appear to significantly affect how the drug is cleared from the body.

Q: Will Xsert change my personality or make me feel 'numb'?

The medicine is intended to modulate mood and emotional stability. While the regulatory label does not specifically address feeling 'numb' or a 'personality change', it advises patients and caregivers to monitor for any significant changes in behavior or emotional state.

Q: Is it normal to have sleep issues (insomnia or vivid dreams) while taking Xsert?

Yes, official safety information lists insomnia (difficulty sleeping) as a very common side effect. Additionally, abnormal or vivid dreams have also been reported by patients using Xsert.

Q: Does Xsert affect blood sugar levels, and is this a concern for people with diabetes?

Regulatory documents mention that cases of altered glycemic control (changes in blood sugar levels) have been reported during the use of Xsert. People with diabetes should use the medicine with caution and monitor blood sugar closely.

Q: What should I do if I miss a dose of Xsert?

According to official patient counseling instructions, if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed. Two doses should not be taken at the same time to make up for the missed one.

Q: Can I take Xsert in the morning or the evening?

Official regulatory instructions state that the medicine is administered once daily and may be taken either in the morning or the evening, depending on patient preference or medical guidance.

Q: How long does Xsert stay in your system after stopping treatment?

Regulatory pharmacological data shows that the medicine has an average terminal elimination half-life of approximately 26 hours. This value indicates how quickly the concentration of the drug decreases in the body over time.

Q: What does the research say about Xsert's effectiveness for Social Anxiety Disorder?

Clinical trial data included in the official label demonstrates that Xsert has been shown to be effective in the short-term treatment of Social Anxiety Disorder (SAD).

Q: Has Xsert been proven effective for long-term treatment of depression?

Yes, studies have shown that Xsert is effective in preventing the recurrence of major depressive episodes. Controlled clinical trials have demonstrated this effect for maintenance treatment lasting up to 44 weeks.

Q: Can Xsert be used to treat symptoms of Premenstrual Dysphoric Disorder (PMDD)?

Yes, official indications state that Xsert is an FDA-approved treatment for the symptoms associated with Premenstrual Dysphoric Disorder (PMDD).

Q: Does Xsert affect my ability to drive or operate machinery?

The official label warns that the medicine may cause somnolence (drowsiness) or affect the ability to think clearly, make decisions, or react quickly. Patients are advised not to drive or operate heavy machinery until they know how the medicine affects them.

Q: What are the signs of an allergic reaction to Xsert that require urgent medical attention?

Serious allergic reactions are possible, and signs that require immediate medical help include swelling of the face, lips, tongue, or throat, as well as the appearance of hives or a skin rash.

Q: Is it possible for Xsert to cause dizziness or lightheadedness?

Dizziness is listed in the official documents as a very common side effect. Additionally, severe dizziness or fainting are considered serious reactions that have been reported.

Q: Is it possible for Xsert to worsen depression or suicidal thoughts when first starting?

Official safety warnings indicate that suicidal thoughts and behaviors may worsen, particularly in patients up to age 24, during the initial weeks of treatment or whenever the dosage is changed. Close monitoring is emphasized.

Q: How is Xsert different from a benzodiazepine (like Xanax) for anxiety?

Xsert is fundamentally different as it is classified as a Selective Serotonin Reuptake Inhibitor (SSRI), working by increasing serotonin in the brain. Unlike benzodiazepines, it is not a controlled substance and does not have significant affinity for benzodiazepine receptors.

Q: Does the time of day I take Xsert matter for sleep side effects?

Since insomnia (difficulty sleeping) is a common side effect and the medicine can be taken in the morning or evening, the time of day may be adjusted in consultation with a healthcare professional to potentially minimize disturbances to sleep.

Q: What does the research show about Xsert for panic attacks?

Regulatory documents confirm that clinical trials have demonstrated Xsert's effectiveness for the treatment of Panic Disorder, helping to reduce the frequency and severity of panic attacks.

Q: Are there any specific dietary restrictions when taking Xsert?

Official warnings advise patients to avoid the consumption of alcohol while taking this medicine. Additionally, patients are advised to avoid grapefruit juice as it may interfere with the body's processing of the drug, potentially increasing its concentration.

Q: What is the half-life of Xsert, and why is this important?

The half-life of Xsert is approximately 26 hours. This pharmacological value is important because it is a factor in determining that dose changes should not occur at intervals of less than one week to allow stable drug levels to be reached.

Q: Why do doctors often prescribe Xsert for a long period, even after symptoms improve?

Research and regulatory documents show that the medicine is effective in reducing the risk of relapse or recurrence of depressive episodes. It is often prescribed for long-term maintenance treatment to help sustain emotional stability after symptoms have improved.

Q: Can Xsert be taken during pregnancy or while breastfeeding?

Use during the third trimester of pregnancy is generally not recommended unless the benefits clearly outweigh the potential risks. Low levels of the drug have been found in breast milk, and use during lactation should be discussed with a health professional.

Q: What is the difference between Xsert and other common antidepressants like fluoxetine or citalopram?

Xsert and the other medicines listed are all classified as Selective Serotonin Reuptake Inhibitors (SSRIs). While they share the same mechanism of action, they have different molecular properties, elimination half-lives (Xsert's is about 26 hours), and individual side effect profiles.

How should Xsert be stored and disposed of?

How to Store and Dispose of Xsert (Sertraline)

Official regulatory documents define strict rules for the storage and disposal of this medicine to ensure stability and public safety.

Storage Requirements

Xsert must be stored at controlled room temperature, typically 20 C to 25 C ( 68 F to 77 F), with permitted excursions up to 30 C. The product must be kept in its tightly closed container and shielded from excess heat and moisture. The medicine must always be stored out of the reach of children.

Disposal Instructions

Unused or expired Xsert should be disposed of primarily through a drug take-back program. If a take-back option is unavailable, the alternative official method is to discard it into household trash after mixing the medicine with an undesirable substance, such as coffee grounds or dirt, and sealing it in a container. It must not be flushed down a toilet or drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Xsert found in:

A-Z Index: